Defining and conceptualising the commercial determinants of health

被引:166
|
作者
Gilmore, Anna B. [1 ,18 ]
Fabbri, Alice [1 ]
Baum, Fran [3 ]
Bertscher, Adam [1 ]
Bondy, Krista [2 ]
Chang, Ha-Joon [4 ]
Demaio, Sandro [5 ]
Erzse, Agnes [6 ]
Freudenberg, Nicholas [7 ]
Friel, Sharon [8 ]
Hofman, Karen J. [6 ]
Johns, Paula [9 ]
Karim, Safura Abdool [6 ]
Lacy-Nichols, Jennifer [10 ]
de Carvalho, Camila Maranha Paes [11 ]
Marten, Robert [12 ]
McKee, Martin [13 ]
Petticrew, Mark [14 ]
Robertson, Lindsay [15 ]
Tangcharoensathien, Viroj [16 ]
Thow, Anne Marie [17 ]
机构
[1] Univ Bath, Dept Hlth, Bath, England
[2] Univ Stirling, Stirling Management Sch, Stirling, Scotland
[3] Univ Adelaide, Stretton Hlth Inst, Adelaide, SA, Australia
[4] Univ London, Sch Oriental & African Studies, Dept Econ, London, England
[5] Victorian Hlth Promot Fdn, Melbourne, Vic, Australia
[6] Univ Witwatersrand, Wits Sch Publ Hlth, Wits Ctr Hlth Econ & Decis Sci, South African Med Res Council, Johannesburg, South Africa
[7] CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY USA
[8] Australian Natl Univ, Menzies Ctr Hlth Governance, Sch Regulat & Global Governance, Acton, ACT, Australia
[9] ACT Hlth Promot, Rio De Janeiro, Brazil
[10] Univ Melbourne, Ctr Hlth Policy, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia
[11] Fluminense Fed Univ, Emilia de Jesus Ferreiro Fac Nutr, Niteroi, Brazil
[12] WHO, Alliance Hlth Policy & Syst Res, Geneva, Switzerland
[13] London Sch Hyg & Trop Med, Dept Hlth Serv Res, London, England
[14] London Sch Hyg & Trop Med, Dept Publ Hlth Environm & Soc, London, England
[15] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand
[16] Minist Publ Hlth, Int Hlth Policy Program, Nonthaburi, Thailand
[17] Univ Sydney, Menzies Ctr Hlth Policy & Econ, Sydney, NSW, Australia
[18] Univ Bath, Dept Hlth, Bath BA2 7AY, England
来源
LANCET | 2023年 / 401卷 / 10383期
基金
英国惠康基金; 英国医学研究理事会; 英国自然环境研究理事会; 英国工程与自然科学研究理事会; 英国经济与社会研究理事会;
关键词
NONCOMMUNICABLE DISEASE RISK; PUBLIC-PRIVATE PARTNERSHIPS; TOBACCO INDUSTRY EFFORTS; ULTRA-PROCESSED FOOD; TRANSNATIONAL CORPORATIONS; INVESTMENT LIBERALIZATION; POLICY-MAKING; SOUTH-AFRICA; ALCOHOL; TRADE;
D O I
10.1016/S0140-6736(23)00013-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although commercial entities can contribute positively to health and society there is growing evidence that the products and practices of some commercial actors-notably the largest transnational corporations-are responsible for escalating rates of avoidable ill health, planetary damage, and social and health inequity; these problems are increasingly referred to as the commercial determinants of health. The climate emergency, the non-communicable disease epidemic, and that just four industry sectors (ie, tobacco, ultra-processed food, fossil fuel, and alcohol) already account for at least a third of global deaths illustrate the scale and huge economic cost of the problem. This paper, the first in a Series on the commercial determinants of health, explains how the shift towards market fundamentalism and increasingly powerful transnational corporations has created a pathological system in which commercial actors are increasingly enabled to cause harm and externalise the costs of doing so. Consequently, as harms to human and planetary health increase, commercial sector wealth and power increase, whereas the countervailing forces having to meet these costs (notably individuals, governments, and civil society organisations) become correspondingly impoverished and disempowered or captured by commercial interests. This power imbalance leads to policy inertia; although many policy solutions are available, they are not being implemented. Health harms are escalating, leaving health-care systems increasingly unable to cope. Governments can and must act to improve, rather than continue to threaten, the wellbeing of future generations, development, and economic growth.
引用
收藏
页码:1194 / 1213
页数:20
相关论文
共 50 条
  • [1] Defining the commercial determinants of health: a systematic review
    de Lacy-Vawdon, Cassandra
    Livingstone, Charles
    [J]. BMC PUBLIC HEALTH, 2020, 20 (01)
  • [2] Defining the commercial determinants of health: a systematic review
    Cassandra de Lacy-Vawdon
    Charles Livingstone
    [J]. BMC Public Health, 20
  • [3] Defining the commercial determinants of health after COVID-19
    Glover, R. E.
    Petticrew, M. P.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31
  • [4] Conceptualising the Commercial Determinants of Health Using a Power Lens: A Review and Synthesis of Existing Frameworks
    Wood, Benjamin
    Baker, Phillip
    Sacks, Gary
    [J]. INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2022, 11 (08) : 1251 - 1261
  • [5] Defining Priorities for Action and Research on the Commercial Determinants of Health: A Conceptual Review
    Freudenberg, Nicholas
    Lee, Kelley
    Buse, Kent
    Collin, Jeff
    Crosbie, Eric
    Friel, Sharon
    Klein, Daniel Eisenkraft
    Lima, Joana Madureira
    Marten, Robert
    Mialon, Melissa
    Zenone, Marco
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2021, 111 (12) : 2202 - 2211
  • [6] Commercial Determinants of Health 3 Commercial determinants of health: future directions
    Friel, Sharon
    Collin, Jeff
    Daube, Mike
    Depoux, Anneliese
    Freudenberg, Nicholas
    Gilmore, Anna B.
    Johns, Paula
    Laar, Amos
    Marten, Robert
    McKee, Martin
    Mialon, Melissa
    [J]. LANCET, 2023, 401 (10383): : 1229 - 1240
  • [7] The commercial determinants of health
    Kickbusch, Ilona
    Allen, Luke
    Franz, Christian
    [J]. LANCET GLOBAL HEALTH, 2016, 4 (12): : E895 - E896
  • [8] The Commercial Determinants of Health
    不详
    [J]. REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2023, 71 (03):
  • [9] The Commercial Determinants of Health
    Lee, Kelley
    [J]. LANCET, 2023, 401 (10370): : 16 - 17
  • [10] INTRODUCTION Commercial Speech and the Commercial Determinants of Health
    Garde, Amandine
    Cabrera, Oscar A.
    [J]. JOURNAL OF LAW MEDICINE & ETHICS, 2022, 50 (02): : 212 - 215